Publications by authors named "Isabelle Portal"

Claim this Profile
C
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.
Georges-Philippe Pageaux, Clovis Lusivika Nzinga, Nathalie Ganne, Didier Samuel, Céline Dorival, Isabelle Portal

BMC Infect Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study.
Laurent Lam, Hélène Fontaine, Marc Bourliere, Clovis Lusivika-Nzinga, Céline Dorival, Isabelle Portal

Clin Res Hepatol Gastroenterol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
Fabrice Carrat, Hélène Fontaine, Céline Dorival, Mélanie Simony, Alpha Diallo, Isabelle Portal

Lancet· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sofosbuvir plus ledipasvir in combination for the treatment of hepatitis C infection.
Marc Bourlière, Xavier Adhoute, Christelle Ansaldi, Valérie Oules, Souad Benali, Isabelle Portal

Expert Rev Gastroenterol Hepatol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B virus reactivation in HBsAg-negative patients is associated with emergence of viral strains with mutated HBsAg and reverse transcriptase.
Philippe Colson, Patrick Borentain, Diane Coso, Anne Motte, Therese Aurran-Schleinitz, Isabelle Portal

Virology· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus NS3 protease genotyping and drug concentration determination during triple therapy with telaprevir or boceprevir for chronic infection with genotype 1 viruses, southeastern France.
Sarah Aherfi, Caroline Solas, Anne Motte, Jacques Moreau, Patrick Borentain, Isabelle Portal

J Med Virol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.
Christophe Hézode, Helene Fontaine, Celine Dorival, Fabien Zoulim, Dominique Larrey, Isabelle Portal

Gastroenterology· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future treatment of patients with HCV cirrhosis.
Marc Bourlière, Asma Khaloun, Claire Wartelle-Bladou, Valérie Oules, Isabelle Portal

Liver Int· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic hepatitis C: treatments of the future.
Marc Bourlière, Asma Khaloun, Claire Wartelle-Bladou, Valérie Oules, Isabelle Portal

Clin Res Hepatol Gastroenterol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus.
Philippe Halfon, Marc Bourliere, Denis Ouzan, Yaakov Maor, Christophe Renou, Isabelle Portal

Eur J Gastroenterol Hepatol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Treatment of hepatitis C].
Marc Bourlière, Asma Khaloun, Paul Castellani, Isabelle Portal, Christelle Ansaldi

Rev Prat· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.
Philippe Halfon, Marc Bourliere, Romaric Deydier, Danielle Botta-Fridlund, Christophe Renou, Isabelle Portal

Am J Gastroenterol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus.
Philippe Halfon, Marc Bourlière, Guillaume Pénaranda, Romaric Deydier, Christophe Renou, Isabelle Portal

Comp Hepatol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daily or three times per week interferon alpha-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone.
Victor de Lédinghen, Pascale Trimoulet, Maria Winnock, Pierre-Henri Bernard, Marc Bourlière, Isabelle Portal

J Hepatol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Treatment of chronic hepatitis C in special groups].
Marc Bourlière, Philippe Halfon, Isabelle Portal

Gastroenterol Clin Biol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Factors related to screening of hepatitis C virus in general medicine].
Michel Rotily, Sandrine Loubière, Johanne Prudhomme, Isabelle Portal, Albert Tran

Gastroenterol Clin Biol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis